Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 23142203)

1.

Utility of adding Primovist magnetic resonance imaging to analysis of hepatocellular carcinoma by liver dynamic computed tomography.

Jin YJ, Nah SY, Lee JW, Lee JI, Jeong S, Lee DH, Kim YS, Cho SG, Jeon YS.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):187-92. doi: 10.1016/j.cgh.2012.11.002. Epub 2012 Nov 6.

PMID:
23142203
2.

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.

Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.

PMID:
20057319
3.
5.

HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.

Kanata N, Yoshikawa T, Ohno Y, Kanda T, Uchida K, Izaki K, Fukumoto T, Ku Y, Itoh T, Kitajima K, Takahashi S, Sugimura K.

Magn Reson Imaging. 2013 Jan;31(1):17-22. doi: 10.1016/j.mri.2012.06.012. Epub 2012 Aug 13.

PMID:
22898685
6.

Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma.

Jin YJ, Lee HC, Lee D, Shim JH, Kim KM, Lim YS, Do KH, Ryu JS.

J Hepatol. 2012 Jun;56(6):1324-9. doi: 10.1016/j.jhep.2011.12.027. Epub 2012 Feb 6.

PMID:
22322236
7.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
8.

Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.

Baird AJ, Amos GJ, Saad NF, Benson MD.

J Med Imaging Radiat Oncol. 2013 Jun;57(3):314-20. doi: 10.1111/1754-9485.12038. Epub 2013 Feb 6.

PMID:
23721140
9.

Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI.

Lee CH, Kim KA, Lee J, Park YS, Choi JW, Park CM.

Eur J Radiol. 2012 Apr;81(4):e605-11. doi: 10.1016/j.ejrad.2011.12.033. Epub 2012 Jan 31.

PMID:
22297180
10.

Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT.

Onishi H, Kim T, Imai Y, Hori M, Nagano H, Nakaya Y, Tsuboyama T, Nakamoto A, Tatsumi M, Kumano S, Okada M, Takamura M, Wakasa K, Tomiyama N, Murakami T.

Eur Radiol. 2012 Apr;22(4):845-54. doi: 10.1007/s00330-011-2316-y. Epub 2011 Nov 7.

PMID:
22057248
11.

Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.

Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.

Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.

PMID:
19838119
12.

Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.

Murakami T, Imai Y, Okada M, Hyodo T, Lee WJ, Kim MJ, Kim T, Choi BI.

Oncology. 2011;81 Suppl 1:86-99. doi: 10.1159/000333267. Epub 2011 Dec 22. Review.

PMID:
22212941
13.

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK.

AJR Am J Roentgenol. 2009 Jun;192(6):1675-81. doi: 10.2214/AJR.08.1262.

PMID:
19457834
14.

Diagnostic imaging of hepatocellular carcinoma: recent progress.

Kudo M.

Oncology. 2011;81 Suppl 1:73-85. doi: 10.1159/000333265. Epub 2011 Dec 22. Review.

PMID:
22212940
15.

Assessing patients with hepatocellular carcinoma meeting the Milan criteria: Is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT?

Cha DI, Lee MW, Kim YK, Kim SH, Park HJ, Rhim H, Lim HK.

J Magn Reson Imaging. 2014 Apr;39(4):842-52. doi: 10.1002/jmri.24237. Epub 2013 Sep 30.

PMID:
24115384
16.

The impact of CT follow-up interval on stages of hepatocellular carcinomas detected during the surveillance of patients with liver cirrhosis.

Chung YE, Kim MJ, Park MS, Choi JY, Lim JS, Kim KA, Kim KW.

AJR Am J Roentgenol. 2012 Oct;199(4):816-21.

PMID:
22997373
17.

Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.

Balci NC, Befeler AS, Bieneman BK, Fattahi R, Saglam S, Havlioglu N.

Acad Radiol. 2009 Aug;16(8):963-8. doi: 10.1016/j.acra.2009.02.010. Epub 2009 Apr 21.

PMID:
19386514
18.

Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.

Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S.

J Magn Reson Imaging. 2011 Jul;34(1):69-78. doi: 10.1002/jmri.22588. Epub 2011 May 19.

PMID:
21598343
19.

Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.

Invest Radiol. 2008 Jul;43(7):504-11. doi: 10.1097/RLI.0b013e3181705cd1.

PMID:
18580333
20.

Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.

Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M, Ohtomo K.

Eur J Radiol. 2011 Nov;80(2):310-5. doi: 10.1016/j.ejrad.2010.07.026. Epub 2010 Aug 21.

PMID:
20732773
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk